Skip to main content

Gut (Bacteria) Check on Parkinson's: Role of Microbiome

January 19, 2017

Our panelists discuss the role of gut bacteria in Parkinson's and how the microbiome (microorganisms that share our body space) may help us understand more about disease onset, progression and medication response.

Webinar Details


Thursday, January 19, 2017


1 hr


12:00 pm ET

  • MJFF offers Continuing Medical Education (CME) credit for practicing health care professionals for each Third Thursday Webinar. Click the link in the Resource List after viewing the webinar to take the post-test survey and receive your CME credit.

    Date of Original Release: January 19, 2017
    Date CME Credit No Longer Available: January 19, 2019

    Learning Objectives

    At the conclusion of this course, participants should be able to:

    • Define what is meant by the terms "gut bacteria" and "microbiome."
    • Explain why researchers investigate the gut in Parkinson's disease.
    • Discuss the possible connections between gut bacteria and Parkinson's disease.
    • Recognize the role diet plays in Parkinson's disease.
    • Identify how researchers could use findings in the gut to measure and/or treat Parkinson's disease.         
    Target Audience

    This educational activity is designed for primary care physicians, family practice physicians, general medicine physicians, geriatricians, general neurologists, movement disorder specialists and any other health care practitioners who manage patients with Parkinson's disease.


    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Oakstone Publishing, LLC and The Michael J. Fox Foundation for Parkinson's Research. The Oakstone Publishing, LLC is accredited by the ACCME to provide continuing medical education for physicians.

    Oakstone Publishing, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


    Oakstone Publishing, LLC has assessed conflict of interest with its faculty, authors, editors and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing, LLC's planners, content reviewers, and editorial staff disclose no relevant commercial interests.


    Dave Iverson
    No disclosures

    Jeff Bronstein MD, PhD
    Professor of Neurology
    Fred Silton Family Chair in Movement Disorders
    Director of Movement Disorders
    David Geffen School of Medicine at UCLA
    No disclosures

    Filip Scheperjans, MD, PhD
    Helsinki University Hospital
    Research Grants: Michael J Fox Foundation, Finnish Medical Foundation, Academy of Finland
    Advisory Role: Herantis Pharma
    Board Membership: NeuroInnovation Oy
    Employment: Hospital District of Helsinki and Uusimaa 
    Honoraria: UCB 
    Ownership Interests: NeuroInnovation Oy
    Patent Copyright License: WO2015/181449A1

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.